Functional activation by central monoamines of human dopamine D4 receptor polymorphic variants coupled to GIRK channels in Xenopus oocytes

European Journal of Pharmacology

Volumn 562, Issue 3, 2007, Pages 165-173

  Wedemeyer, Carolina ^a   Goutman, Juan D ^a   Avale, María E ^a   Franchini, Lucía F ^a   Rubinstein, Marcelo ^a   Calvo, Daniel J ^a  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

Author keywords

Dopamine D4 receptor; GIRK channels; Noradrenaline; Polymorphic variants; Serotonin

Indexed keywords

DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; MONOAMINE; NORADRENALIN; SEROTONIN; SONEPIPRAZOLE;

ALLELE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FROG; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; ION CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SEQUENCE ANALYSIS; VOLTAGE CLAMP; XENOPUS LAEVIS;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ELECTROPHYSIOLOGY; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; NOREPINEPHRINE; OOCYTES; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; SEROTONIN; XENOPUS LAEVIS;

EID: 34147205853     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.055     Document Type: Article

References (46)

1. 4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res. 752 (1997) 26-34
2. 4 receptor variants. J. Neurochem. 65 (1995) 1157-1165
3. Benes F.M., Taylor J.B., and Cunningham M.C. Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology. Cereb. Cortex 10 (2000) 1014-1027
4. Carboni E., and Silvagni A. Dopamine reuptake by norepinephrine neurons: exception or rule?. Crit. Rev. Neurobiol. 16 (2004) 121-128
5. Cornil C.A., Dejace C., Ball G.F., and Balthazart J. Dopamine modulates male sexual behavior in Japanese quail in part via actions on noradrenergic receptors. Behav. Brain Res. 163 (2005) 42-57
6. 4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine. Eur. J. Pharmacol. 531 (2006) 20-24
7. 4 receptor locus. Hum. Genet. 98 (1996) 91-101
8. Devoto P., Flore G., Pani L., and Gessa G.L. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatry 6 (2001) 657-664
9. 4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat. Genet. 12 (1996) 78-80
10. Emson P.C., and Koob G.F. The origin and distribution of dopamine-containing afferents to the rat frontal cortex. Brain Res. 142 (1978) 249-267
11. 4 receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry 158 (2001) 1052-1057
12. Freddolino P.L., Kalani M.Y., Vaidehi N., Floriano W.B., Hall S.E., Trabanino R.J., Kam V.W., and Goddard III W.A. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2736-2741
13. Fuster J.M. The prefrontal cortex-an update: time is of the essence. Neuron 30 (2001) 319-333
14. Goldman-Rakic P.S. Anatomical and functional circuits in prefrontal cortex of nonhuman primates. Relevance to epilepsy. Adv. Neurol. 66 (1995) 51-65
15. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 14 (1995) 477-485
16. 4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol. Psychiatry 8 (2003) 536-545
17. Jovanovic V., Guan H.C., and Van Tol H.H. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants. Pharmacogenetics 9 (1999) 561-568
18. Kalani M.Y., Vaidehi N., Hall S.E., Trabanino R.J., Freddolino P.L., Kalani M.A., Floriano W.B., Kam V.W., and Goddard III W.A. The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3815-3820
19. 4 receptor. J. Neurochem. 68 (1997) 804-812
20. Lavine N., Ethier N., Oak J.N., Pei L., Liu F., Trieu P., Rebois R.V., Bouvier M., Hebert T.E., and Van Tol H.H. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277 (2002) 46010-46019
21. Lee S.P., Xie Z., Varghese G., Nguyen T., O'Dowd B.F., and George S.R. Oligomerization of dopamine and serotonin receptors. Neuropsychopharmacology 23 (2000) S32-S40
22. Manivet P., Schneider B., Smith J.C., Choi D.S., Maroteaux L., Kellermann O., and Launay J.M. The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis. J. Biol. Chem. 277 (2002) 17170-17178
23. Miledi R. Transplanting Receptors from Brains into Oocytes. Fidia Research Foundation Neuroscience Award Lectures vol. 3 (1989), Raven Press Ltd., New York 57-87
24. 4 receptors in GABAergic neurons of the primate brain. Nature 381 (1996) 245-248
25. Neve K.A. Dopamine receptors. In: Schmidt W.J., and Reith M.E. (Eds). Dopamine and Glutamate in Psychiatric Disorders (2005), Humana Press Inc., Totowa, New Jersey 3-43
26. Newman-Tancredi A., Audinot-Bouchez V., Gobert A., and Millan M.J. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur. J. Pharmacol. 319 (1997) 379-383
27. 4 receptor. Biochemistry 37 (1998) 15726-15736
28. Oz M., Zhang L., Rotondo A., Sun H., and Morales M. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors. Synapse 50 (2003) 303-313
29. 4 receptor gene: novelty or nonsense?. Neuropsychopharmacology 21 (1999) 3-16
30. + channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively. Neuropharmacology 37 (1998) 983-987
31. Reader T.A. Distribution of catecholamines and serotonin in the rat cerebral cortex: absolute levels and relative proportions. J. Neural Transm. 50 (1981) 13-27
32. 4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 (1997) 991-1001
33. 4 receptor-deficient mice display cortical hyperexcitability. J. Neurosci. 21 (2001) 3756-3763
34. Seamans J.K., and Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 74 (2004) 1-58
35. Seutin V. Dopaminergic neurones: much more than dopamine?. Br. J. Pharmacol. 146 (2005) 167-169
36. Stockmeier C.A., DiCarlo J.J., Zhang Y., Thompson P., and Meltzer H.Y. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. J. Pharmacol. Exp. Ther. 266 (1993) 1374-1384
37. 4 receptor with high affinity for the antipsychotic clozapine. Nature 350 (1991) 610-614
38. 4 receptor variants in the human population. Nature 358 (1992) 149-152
39. 4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J. Neurosci. 22 (2002) 9185-9193
40. 4 signaling in prefrontal cortex. J. Neurosci. 23 (2003) 9852-9861
41. 4 (DRD4) gene locus. Am. J. Hum. Genet. 74 (2004) 931-944
42. 4 dopamine receptors couple to G protein-regulated potassium channels in Xenopus oocytes. Mol. Pharmacol. 49 (1996) 656-661
43. White S.R., Obradovic T., Imel K.M., and Wheaton M.J. The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog. Neurobiol. 49 (1996) 455-479
44. Woodward R.M., Panicker M.M., and Miledi R. Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4708-4712
45. Yamamoto B.K., and Novotney S. Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71 (1998) 274-280
46. Zhou F.M., Liang Y., Salas R., Zhang L., De Biasi M., and Dani J.A. Corelease of dopamine and serotonin from striatal dopamine terminals. Neuron 46 (2005) 65-74